Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
-99.99%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Cogent Biosciences, Inc.
Market Cap
$5.16B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.18B
Net Profit Margin
-7.35%
TTM Avg
-71.56%
3Y Avg
-118.55%
5Y Avg
-116.04%
Market Cap
$5.15B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-101.30%
5Y Avg
-277.86%
Market Cap
$5.21B
Net Profit Margin
13.44%
TTM Avg
5.37%
3Y Avg
-1.91%
5Y Avg
0.03%
Market Cap
$5.25B
Net Profit Margin
25.48%
TTM Avg
34.77%
3Y Avg
31.87%
5Y Avg
32.80%
Market Cap
$5.25B
Net Profit Margin
-3368.72%
TTM Avg
-8808.10%
3Y Avg
-41695.11%
5Y Avg
-35876.65%
Market Cap
$5.05B
Net Profit Margin
9.22%
TTM Avg
8.68%
3Y Avg
7.83%
5Y Avg
5.80%
Market Cap
$5.01B
Net Profit Margin
11.18%
TTM Avg
4.08%
3Y Avg
-1.40%
5Y Avg
-2.75%
Market Cap
$5.34B
Net Profit Margin
-3.80%
TTM Avg
-2.80%
3Y Avg
-38.10%
5Y Avg
-60.79%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | $5.16B | 0.00% | 0.00% | 0.00% | 0.00% |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.18B | -7.35% | -71.56% | -118.55% | -116.04% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.15B | 0.00% | 0.00% | -101.30% | -277.86% |
| Sotera Health Company (SHC)vs › | $5.21B | 13.44% | 5.37% | -1.91% | 0.03% |
| Doximity, Inc. (DOCS)vs › | $5.25B | 25.48% | 34.77% | 31.87% | 32.80% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.25B | -3368.72% | -8808.10% | -41695.11% | -35876.65% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.05B | 9.22% | 8.68% | 7.83% | 5.80% |
| Waystar Holding Corp. (WAY)vs › | $5.01B | 11.18% | 4.08% | -1.40% | -2.75% |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.34B | -3.80% | -2.80% | -38.10% | -60.79% |
| Erasca, Inc. (ERAS)vs › | $4.95B | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | -16020.19% |
| 2020-06-30 | -1400.19% |
| 2020-03-31 | -86.67% |
| 2019-12-31 | 15.02% |
| 2019-09-30 | -1168.92% |
| 2019-06-30 | -335.12% |
| 2019-03-31 | -382.93% |
| 2018-12-31 | -226.18% |
| 2018-09-30 | -497.70% |
| 2018-06-30 | -541.60% |
| 2018-03-31 | -303.38% |
| 2017-12-31 | -315.12% |
| 2017-09-30 | -300.30% |
| 2017-06-30 | -282.01% |
| 2017-03-31 | -325.07% |
| 2016-09-30 | -18.68% |
| 2015-09-30 | -439.32% |
